Suscribirse

Component positioning in primary total hip replacement: A prospective comparative study of two anterolateral approaches, minimally invasive versus gluteus medius hemimyotomy - 10/02/11

Doi : 10.1016/j.otsr.2010.05.013 
F. Mouilhade a, , J. Matsoukis b, P. Oger c, C. Mandereau a, V. Brzakala a, F. Dujardin a
a Academic Department of Orthopedic Surgery and Traumatology, Rouen University Hospital, 1, rue de Germont, 76000 Rouen, France 
b Orthopedic Department, Le Havre Hospital Group, J. Monod Hospital, 29, rue Pierre-Mendès, 76290 Montivilliers, France 
c Orthopedic Department, Mignot Hospital, 177, route de Versailles, 78157 Le Chesnay, France 

Corresponding author. Tel.: +33 0 232880160.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Summary

Introduction

One factor of implant survivorship in total hip replacement (THR) is the quality of implant choice and positioning. The purported advantages of minimally invasive approaches are faster recovery, shorter hospital stay and less per-operative blood loss. On the other hand, there have been many reports of higher complication rates, and doubts as to the quality of implant positioning.

Hypothesis

The quest to minimize tissue damage is at the cost of THR positioning quality.

Objectives

To assess implant positioning in a prospective comparative continuous multicenter series.

Patients and methods

Between 2008 and 2009, a prospective comparative study was conducted on a continuous series of 141 THRs. Ninety-two were performed in two centers, using a minimally invasive Watson-Jones approach; the other 49, performed in a 3rd center, used an anterolateral approach with anterior hemimyotomy. The surgeons were in all cases experienced in their technique. Short-term follow-up comprised clinical and functional (Postel Merle d’Aubigné (PMA), Harris, SF12, WOMAC) and biological assessment (serum creatine phosphokinase (CPK), myoglobinemia, hematocrit) and analysis of complications and of implant positioning on X-ray and CT-scan.

Results

On the Watson-Jones approach, surgery time was longer; day-1 analgesic administration was lower; PMA, Harris and WOMAC scores were better at 6 weeks; and CPK levels were lower at 24 and 48hours. There were no significant differences on the other clinical and biological criteria. Implant positioning analysis revealed significantly greater combined anteversion and greater variation in acetabular inclination mean with the Watson-Jones approach, but no differences in cup positioning, femoral stem positioning, or limb length discrepancy.

Discussion

The minimally invasive Watson-Jones approach provided faster recovery and less muscular damage. However, implant positioning was less precise in terms of acetabular cup inclination.

Level of evidence

Level III. Prospective, comparative, non-randomized.

El texto completo de este artículo está disponible en PDF.

Keywords : Total hip arthroplasty, Mini-incision, Rottinger, Watson-Jones, Implant positioning


Esquema


© 2010  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 97 - N° 1

P. 14-21 - février 2011 Regresar al número
Artículo precedente Artículo precedente
  • Treatment of recurrent THR dislocation using of a cementless dual-mobility cup: A 59 cases series with a mean 8 years’ follow-up
  • F. Leiber-Wackenheim, B. Brunschweiler, M. Ehlinger, A. Gabrion, P. Mertl
| Artículo siguiente Artículo siguiente
  • Non-simultaneous bilateral hip fracture: Epidemiologic study of 241 hip fractures
  • E. Gaumetou, S. Zilber, P. Hernigou

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.